Heart Valve Diseases Clinical Trial
— SEPOfficial title:
SEP-study; The Assessment of Normal Values in Stress Echocardiographic Parameters in Patients After Successful Mitral Valve Repair for Organic Mitral Valve Regurgitation
Verified date | December 2015 |
Source | UMC Utrecht |
Contact | n/a |
Is FDA regulated | No |
Health authority | Netherlands: Medical Ethics Review Committee (METC) |
Study type | Observational |
Surgical treatment is the only approach with potentially defined clinical success for
organic mitral valve (MV) regurgitation. Recurrent or persistent complaints after initial
successful MV repair is a clinical challenge in current practice. Especially when echo
parameters at rest are within or near normal ranges and patients presenting
disproportionately symptomatic in relation to the observed results. However, while MV
regurgitation is a hemodynamic disease, currently used 2-dimensional (2D) transthoracic
echocardiography (TTE) at rest lacks information about hemodynamic changes. Physical stress
echocardiography is a promising technique to complement nowadays rest TTE in order to
improve interpretation of hemodynamic changes. However, normal values for exercise echo are
lacking in this postoperative patients cohort. A prospective, observational trial to
determine normal values in stress echocardiographic parameters in asymptomatic patients
after successful MV repair for organic MV regurgitation, is therefore highly needed.
Purpose of the SEP- study is to determine normal values in stress echocardiographic
parameters in asymptomatic patients at least 6 months after successful MV repair for organic
MV regurgitation. These normal values for stress echo are of utmost importance to correctly
and accurate interpret stress echo results during postoperative follow-up and to improve
clinical decision making in patients post MV repair.
Status | Completed |
Enrollment | 25 |
Est. completion date | December 2015 |
Est. primary completion date | December 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Age =18 years; - Male or female from all ethnicities; - At least 6 months post successful, isolated MV repair. S - Asymptomatic Exclusion Criteria: - Pulmonary hypertension >50 mmHg at rest; - Atrial fibrillation (AF) at time of study related stress echo test; - Known contraindication or incapability to perform peak exercise or inability to perform physical stress testing; - LVEF <45%; - NYHA class II and more. - Other heart valve disease of more than mild severity; - Concomitant surgery during MV repair, e.g. MAZE, TVP procedure; - Prior heart valve surgery; - Congenital heart disease; - Disabling comorbidity, e.g. chronic obstructive pulmonary disease (COPD); - Unable to provide informed consent |
Time Perspective: Cross-Sectional
Country | Name | City | State |
---|---|---|---|
Netherlands | University Medical Center Utrecht (UMC Utrecht) | Utrecht |
Lead Sponsor | Collaborator |
---|---|
UMC Utrecht |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Echocardiographic parameter: Peak mitral valve mean gradient (mmHg) | Echocardiographic measured mitral valve mean gradient at peak physical exercise | at least 6 months after successful MV repair | No |
Primary | Echocardiographic parameter: Peak systolic pulmonary artery pressure (sPAP, mmHg) | Echocardiographic measured sPAP at peak physical exercise | at least 6 months after successful MV repair | No |
Primary | Echocardiographic parameter: Increase in mitral valve regurgitation grade (grade 0-4, according to ESC guidelines) | Echocardiographic measured increase in mitral valve regurgitation at peak physical exercise during physical stress echo, compared to rest echo. Grading of mitral regurgitation will be performed according to the ESC guidelines. | at least 6 months after successful MV repair | No |
Secondary | Echocardiographic parameter: Left ventricular function (LVF, quality description) | Echocardiographic measured LVF quality at rest and peak physical exercise | at least 6 months after successful MV repair | No |
Secondary | Echocardiographic parameter: Mitral valve area (MVA, cm2) | Echocardiographic measured MVA at rest and peak physical exercise | at least 6 months after successful MV repair | No |
Secondary | Echocardiographic parameter: Peak mitral valve peak gradient (mmHg) | Echocardiographic measured mitral valve peak gradient at peak physical exercise | at least 6 months after successful MV repair | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02865798 -
China Senile Valvular Heart Disease Cohort Study
|
N/A | |
Completed |
NCT02249000 -
BIOVALVE - I / II Clincial Investigation
|
N/A | |
Completed |
NCT02297334 -
Removal of Cytokines During Extracorporeal Circulation in Cardiac Surgery
|
N/A | |
Completed |
NCT01591018 -
SONOlysis in Risk REduction of Symptomatic and Silent Brain infarCtions dUring Cardiac surgEry
|
Phase 3 | |
Completed |
NCT01428947 -
Does Coronary Angiography Cause Cognitive Dysfunction?
|
N/A | |
Recruiting |
NCT01231776 -
Acupuncture Improves Sleep in Patients Undergoing Cardiopulmonary Bypass
|
N/A | |
Terminated |
NCT01116037 -
ATS 3f(r) Aortic Bioprosthesis Model 1000 Post Approval Study
|
N/A | |
Completed |
NCT00371891 -
Ontario Multidetector Computed Tomographic (MDCT) Coronary Angiography Study (OMCAS)
|
Phase 4 | |
Terminated |
NCT03632967 -
Early Feasibility Study of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System
|
N/A | |
Recruiting |
NCT05728047 -
Evaluation of Systemic Microcirculation of Patients Undergoing Heart Valve Surgery
|
||
Not yet recruiting |
NCT05539261 -
Research on Neurological Prognosis of Patients Undergoing Heart Valve Surgery
|
||
Completed |
NCT05479968 -
Spectroscopic Assessment of Intramyocardial Oxygen Saturation Feasibility During Open-heart Surgery
|
||
Completed |
NCT03527381 -
Nitric Oxide in Cardiopulmonary Bypass for Renal Protection in Cardiac Surgery
|
Phase 1/Phase 2 | |
Completed |
NCT03664102 -
Automated Fastener Device Versus Manually Tied Knot in MiAVR
|
||
Recruiting |
NCT06084091 -
Spectroscopic Assessment of Intramyocardial Oxygen Saturation During Open-Heart Surgery
|
||
Completed |
NCT05836467 -
Is Myocardial Revascularization Really Necessary in Patients With ≥50-70% Coronary Stenosis Undergoing Valvular Surgery?
|
||
Recruiting |
NCT05933083 -
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
|
N/A | |
Recruiting |
NCT04445012 -
Cardiovascular Acoustics and an Intelligent Stethoscope
|
||
Active, not recruiting |
NCT02732691 -
JENAVALVE AS EFS TRIAL: Pericardial TAVR Aortic Stenosis Study
|
N/A | |
Completed |
NCT02981953 -
TRI-REPAIR: TrIcuspid Regurgitation RePAIr With CaRdioband Transcatheter System
|
N/A |